Best Michael J Fox Foundation Podcasts (2025)

1
Navigating Employment with Parkinson's 47:20

Play Pause

2h ago47:20

47:20

A Parkinson’s disease (PD) diagnosis can impact many areas of life, including how you get work done and think about your career. It can lead to questions like: Should I disclose my diagnosis to my employer and colleagues? How do I adapt my work around my symptoms? What legal protections do I have? Tune into this episode of The Michael J. Fox Founda…

1
A Finnish biotech is making progress on Parkinson's disease with support from The Michael J. Fox Foundation 38:02

11d ago38:02

38:02

Parkinsons disease impacts some 10 million people worldwide and current approaches to treating the condition almost exclusively focus on addressing symptoms – there is, as of yet, no cure. One Finnish biotech, however, is not focused on alleviating symptoms but on modifying the course of the disease itself. Their hope is to be able to stop and even…

1
AION Labs is building innovative biotechs with top pharma partners in Israel 42:09

2h ago42:09

42:09

How do you do science, how do you build biotechs, and how can you drive innovation in a country that’s almost always under threat? These are questions that this week’s guest, Mati Gill, CEO of AION Labs in Israel, is perfectly positioned to answer. AION Labs has an innovative company creation process that empowers scientists and startups to tackle …

1
Setting Your Teams Up For Success with Dolphins Cancer Challenge’s Javier Sanchez 33:39

4d ago33:39

33:39

Leading a P2P campaign means managing multiple moving pieces—fundraisers with different experience levels, corporate partners with varying expectations and internal staff with diverse skill sets. But the most successful leaders know that underneath all this complexity lies a simple truth: understanding what drives each person is the key to keeping …

1
Navigating the biotech development journey from first steps to global scale with Lonza 50:40

4d ago50:40

50:40

Lonza is one of the world’s largest contract development and manufacturing organizations (CDMOs), dedicated to serving the healthcare industry. They work alongside a broad range of customers – from emerging biotechs to top global pharmaceutical companies – to transform therapeutic discoveries into life-saving and life-enhancing treatments for their…

1
GOLDEN GIRLS 2.0 INTERVIEW WITH SAVENIA FALQUIST OF HOMESHARE; Taylor Swift’s Caregiving News, Caregiver Grief Awareness & Help, Friendships & Health, Relaxation Day Tips, Parkinson’s and Golf, the Beach ...

15d ago

—

Our August episode has host and gerontologist, Sherri Snelling, talking with Savenia Falquist of HomeShare Oregon about a roommate finding service for older adults. Looking to support older adults who are living at home and help them with avoiding loneliness while also boosting their financial resilience, this is what we call “Golden Girls 2.0.” Sa…

1
Advances in Stem Cell Science for Parkinson’s (Webinar Audio) 52:29

13d ago52:29

52:29

Researchers are investigating many options to treat Parkinson’s disease (PD) with stem cells, including reprogramming them to replace lost dopamine-producing neurons and creating supportive brain cells to keep neurons healthy. Tune into audio from this Third Thursdays Webinar to listen to our panel of experts discuss the latest stem cell research a…

1
How RNAi is expanding from a therapy of choice for rare disease into treating common conditions 48:01

18d ago48:01

48:01

RNAi has changed the way that rare diseases are treated - is it about to do the same for more common conditions? Alnylam was the very first company to translate RNAi from Nobel Prize winning science into a commercially scalable platform. Founded in 2002, the company today has five different RNAi therapies on the market and a pipeline that continues…

1
Ask Us Anything About Parkinson’s and Relationships 39:44

21d ago39:44

39:44

How do I tell my children about my Parkinson’s disease (PD) diagnosis? How do I explain a tremor to my grandkids? How can I support my parent with Parkinson’s from a distance? How can my spouse and I communicate around a symptom of apathy? Every year our community submits thousands of questions online and at in-person events. Many are about Parkins…

1
Are next-generation psychedelics the way forward for addressing treatment resistant depression? 49:07

25d ago49:07

49:07

Nearly 1 billion people around the world suffer from mental health disorders, with the global economic cost of those disorders expected to reach $6 trillion by 2030. One of the most common of those mental health disorders is depressive disorder, commonly called depression, with some 280 million people suffering from either mild, moderate or severe …

1
Day One DNA: How and why the UK is betting on whole genome sequencing for every newborn 49:57

1M ago49:57

49:57

The UK is preparing to change the game for healthcare - but why, how, and what will it cost? Recently the UK government announced plans to sequence the DNA of every baby born in that country. A part of the country’s 10 Year Health Plan, the program aims to identify rare genetic diseases early, prevent harms from delayed treatment and reduce future …

1
Meatly's innovative cultivated meat is already delighting pets, are humans next? 38:45

1M ago38:45

38:45

Is cultivated meat the future of pet food? And is there a place for cultivated meat on human dinner tables, too? Traditional agricultural methods are slow, require large tracts of land, significant energy and environmental inputs, and – somewhat obviously – the slaughter of hundreds of millions of animals every year. Cultivated meat – that is meat …

1
Cryoport Systems on the state of the ATMP market and the importance of supply chain resilience 48:30

2M ago48:30

48:30

With supply chain management and optimization, risk management, and the capacity to address global markets efficiently and effectively top of mind for all growing biotechs, I'm excited to be joined by Alison Pritchard, Vice President, Business Development at Cryoport Systems, to learn more about how they support life science innovators worldwide. C…

1
NATIONAL DAY OF JOY WITH SAUDIA GAJADHAR – COMFORT KEEPERS; Sandwich Generation Month latest news & lifestyle changes, International Self-Care Day July 24, Rucking is the New Walking, Joy vs. Happiness ...

2M ago

—

Our July episode has host and gerontologist, Sherri Snelling, talking with Saudia Gajadhar, Chief Happiness Officer at Comfort Keepers about this year’s National Day of Joy survey among older adults and family caregivers and Comfort Keepers’ role in the new PBS documentary, “Caregiving.” In CAREGIVER WELLNESS NEWS, Sherri shares the latest stats to…

1
Finding the Right Tech Tools for Your Parkinson’s Journey (Webinar Audio) 57:18

2M ago57:18

57:18

Technology can offer people living with Parkinson’s disease (PD) much needed support in several areas of life, from apps to keep track of medication timing, wearables to help smooth gait, websites to monitor symptoms and more. Tune into audio from this Third Thursdays Webinar to listen to our panel of experts discuss how tech tools can be incorpora…

1
Deploying P2P Strategies For Emergency Response with American Red Cross' Jessi Woomer 31:03

2M ago31:03

31:03

Crisis fundraising operates on a different timeline than traditional campaigns. When disaster hits, organizations have a critical 24-hour window to mobilize resources and activate their networks. But what separates organizations that thrive in crisis from those that scramble? The difference lies in preparation—having systems, messages, and communit…

1
Taking the fight to inflammatory disease: InflaRx’s first-in-class C5a/C5aR signaling pathway strategy 39:24

2M ago39:24

39:24

Inflammatory diseases involve excessive or ongoing inflammation that damages tissues and affects many different human systems, including digestion, immunity, circulation, breathing, and the nervous system. The demand for anti-inflammatory treatments is growing quickly and is tipped to top a quarter of a trillion dollars within the decade as cases i…

1
What Imaging Tech Can Reveal About Parkinson's 36:06

2M ago36:06

36:06

Advances in imaging technology offer researchers a window into how Parkinson’s disease affects the brain, which could reshape how the disease is diagnosed and treated. In this episode of The Michael J. Fox Foundation Parkinson’s Podcast, in its award-winning Parkinson’s Science POV series, David Kumbroch, senior science writer at MJFF, lead a conve…

1
How OMass Therapeutics is tackling congenital adrenal hyperplasia, a rare genetic disorder 34:27

2M ago34:27

34:27

Ros Deegan is an industry leader and the CEO of OMass Therapeutics, an Oxford-based biotechnology company discovering medicines against highly-validated target ecosystems, such as membrane proteins or intracellular complexes. OMass’s MC2 program targeting Congenital Adrenal Hyperplasia, or CAH, is set to enter the clinic this year and in our interv…

1
Building Your Best Parkinson’s Care Team (Webinar Audio) 54:27

2M ago54:27

54:27

Having a network of health care professionals, loved ones and community members as part of a care team has shown to improve the quality of life for those living with Parkinson’s disease (PD) and their loved ones. Tune into audio from this Third Thursdays Webinar to listen to our panel of experts discuss how to make the most of your appointments, fi…

1
Embracing A Builder's Mindset with Parkinson's Foundation's Kayln Henkel 33:24

2M ago33:24

33:24

There's a fundamental difference between inheriting a well-oiled P2P machine and building one from scratch. When you're tasked with creating systems, culture and infrastructure that need to scale alongside explosive organizational growth, you're not just managing programs - you're architecting the future. But here's what most people don't realize: …

1
AARP CAREGIVER ANSWER BOOK AUTHORS BARRY JACOBS & JULIA MAYER; Alzheimer’s & Brain Health Month Blood Tests, Popcorn Brain; Sunshine Cures for Alz and MS; Employer Wellness Month, Sound Bathing & Gardening ...

2M ago

—

For our June episode host and gerontologist, Sherri Snelling, talks with the authors of the new “AARP Caregiver Answer Book” – Barry Jacobs and Julia Mayer. They share some of the insights from the book including the difference in caring for a spouse versus an older parent, how and why families need to have the caregiving conversation, how to adopt…

1
Persica Pharmaceuticals is treating the cause of chronic lower back pain, not just the symptoms 38:29

2M ago38:29

38:29

The World Health Organization reports that more than 600 million people suffer from lower back pain globally, making it the leading cause of disability worldwide. Chronic lower back pain – where the pain persists for more than 3 months – develops in between 5 and 10% of all lower back pain cases, with life-altering impacts for patients. And that’s …

1
Humacyte: Saving lives with lab-grown blood vessels in conflict zones 36:27

3M ago36:27

36:27

Trauma surgeons in Ukraine operating theaters saved lives and limbs thanks to the innovative lab-grown blood vessels from US biotech, Humacyte. Humacyte is pioneering a platform that enables the investigation, development, and manufacture of bioengineered human tissues and organs that are designed to be universally implantable, off-the-shelf, and r…

1
Aligning Marketing And Field Teams For P2P Success with Wounded Warrior Project's Brandi Glover 30:07

3M ago30:07

30:07

In P2P fundraising, there can often be a disconnect between the excitement marketing generates and the direct recruitment strategies implemented by local field teams. The result? Frustrated participants, overwhelmed staff and missed opportunities to achieve participation goals and build lasting relationships with supporters. But what if marketing a…

1
Special Episode: The 2025 BIO International Convention 38:20

3M ago38:20

38:20

Much of the attention of the biotech industry has been focused on the city of Boston this week as the annual BIO International Convention hit town. BIO is the world’s largest partnering conference for the biopharma industry and thousands of innovators, out-licensors, venture capitalists, top pharma dealmakers, thought leaders and more than a few po…

1
Understanding the Experience of LGBTQ+ People Living with Parkinson’s Disease 45:03

3M ago45:03

45:03

Life with Parkinson’s disease (PD) is shaped by myriad factors, including sexual orientation and gender identity that shape access to care, lifestyle decisions and more. In this episode of The Michael J. Fox Foundation’s Parkinson’s Podcast, our expert panel shares their personal stories and discusses the ongoing research into the health concerns a…

1
Alex Telford on AI, drug discovery, digital twins, and the most interesting questions in biotech 46:26

3M ago46:26

46:26

What are the most interesting questions in biotech, and is it even possible to find answers to those questions? Alex Telford is the co-founder of Convoke and a biotech blogger from the San Francisco Bay Area. His blog post, 'Some questions about biotech that I find interesting' provoked conversations online as readers engaged with questions about t…

1
Growing Your “Share Of Community” Through P2P with AIDS Foundation Chicago’s Jonathan Harris & Christina Robinson 31:10

3M ago31:10

31:10

Marketers love to throw around terms like “share of voice” and “share of wallet” - ways to track how much attention or spending a brand commands. But in peer-to-peer fundraising, there’s a different kind of share that matters more. Growing your “share of community” is about going deeper with the people closest to your cause - the ones who feel seen…

1
Corporate venture capital and biotechnology in 2025: challenges, opportunities, and threats 42:12

3M ago42:12

42:12

When biotechs start fundraising they regularly turn to the venture capital market seeking investment. The pool of VC money can be large, and part of that pool is corporate venture capital. Backed by firms keen to identify the next big thing in biotechnology, corporate VC money can be an attractive way for biotechs to raise funds privately while ben…

1
The state of biotech finance and fundraising in Q2 2025 with Baker McKenzie 39:27

4M ago39:27

39:27

Biotechnology has always been a dynamic domain, but the world of finance that provides the fuel for the fire is just as vibrant. Trying to predict where the market for biotech investment is heading is always risky but for experts like Baker McKenzie’s Roel Meers, understanding where the market is moving is where he eats. I spoke to Roel this week t…

1
Changing the Narrative: Destigmatizing Parkinson’s Disease (Webinar Audio) 53:07

4M ago53:07

53:07

The beliefs and perceptions that friends, family, employers and even strangers hold about Parkinson’s disease (PD) shape the experience of living with the disease. Facing misperceptions and stigma can cause isolation and worsen symptoms. Tune into audio from this Third Thursdays Webinar to listen to our panel of experts have a candid and compassion…

1
Activating The Content Creator Community Through P2P with The Immune Deficiency Foundation’s Aimee Yrlas-Simpson & Angela Ridenour 39:13

4M ago39:13

39:13

Celebrity gossip magazines love to remind us: "Stars — they’re just like us!" And while the world of digital creators and streamers can feel like a distant universe, the truth is that these online personalities aren’t so different from the rest of us. As P2P fundraising increasingly intersects with the creator community, it’s easy to view streamers…

1
How generative AI and 'Photoshop for proteins' are transforming biopharma R&D 35:00

4M ago35:00

35:00

Generative artificial intelligence (GenAI) is already changing how people research, communicate, and interact, but its biggest impacts on biotech are still to come. Cradle is a Dutch-Swiss biotech startup founded in 2021 that has developed a web-based software platform leveraging GenAI to accelerate protein design and optimization, aiding scientist…

1
How Engagement Helps Your Journey with Parkinson's 41:02

4M ago41:02

41:02

There are so many ways to get involved with Parkinson’s disease, from community building to advocacy, research participation to fundraising. Taking that first step toward involvement can be daunting, but many people say it’s a critical part of living well with the disease. In this episode of The Michael J. Fox Foundation Parkinson’s Podcast, member…

1
ELDER LAW ATTORNEY HARRY MARGOLIS; LINDA KAFKA OF NEURODESIGN ACADEMY; Older Americans Month; May Mental Health Month; Pop Culture: Martin Sheen, Bradley Cooper, Seth and Lauren Miller Rogen - New Films ... 1:37:48

4M ago1:37:48

1:37:48

May is a BIG month and we have two great guests for this episode: Harry Margolis, Elder Law Attorney and Linda Kafka, Founder/Principal of Neuro Design Academy. Since May is both National Elder Law Month and Home Modification Month, these two experts are perfect for this episode to share valuable information caregivers do not want to miss! In our C…

1
Fighting mucopolysaccharidosis type I, a rare disease, by reprogramming B-cells 33:52

4M ago33:52

33:52

There are cell therapies, gene therapies, and biologics – and then there is Immusoft. Immusoft sits at the nexus point of some of the most innovative approaches in biopharma, and their Immune System Programming platform is unique in its capacity to address the rare disease, MPS I. This week we talk with Immusoft CEO Sean Ainsworth to learn more abo…

1
Assessing Opportunities For New Market Growth with The ALS Association’s Cliff Whitlock 31:29

4M ago31:29

31:29

In the early days of peer-to-peer fundraising events, one of the fastest ways to grow a program was to launch events in new markets. But many organizations scaled back over time, whether due to strategic shifts or limited resources. So what happens when it’s time to grow again? How do you evaluate new opportunities and ensure long-term success? Exp…

1
Inside Flagship Pioneering's strategy: How this VC turns ideas into biotech giants 44:25

4M ago44:25

44:25

Flagship Pioneering doesn't go out to find the next big thing in biotech when investing their billions in fund capital - instead, they take a different route. Flagship Pioneering has founded more than 100 companies in the life sciences worth in total an estimated $75 billion. With a proven model for biotech startup success and a culture designed to…

1
TCR-NK: A novel cell therapy transforming cancer treatment 34:00

4M ago34:00

34:00

Are TCR-NK treatments the next big thing in cell therapies for cancer patients? As biotechs and pharma companies continue to innovate to address patient needs in oncology, T-cell receptor therapies, or TCR-Ts, are attracting significant interest and investment. There are already some promising results for TCR-Ts tackling solid tumors – but one Norw…

1
Inspiring Your P2P Community With A Bold, Audacious Goal With Pat Morrissey, Team Human Powered Potential & Liz Deimer, The Michael J. Fox Foundation For Parkinson’s Research 45:21

5M ago45:21

45:21

In the P2P fundraising world, we often look to the spark of organic, supporter-led moments like the Ice Bucket Challenge as examples of what’s possible when passion meets purpose. But when lightning strikes, are you ready to catch it? This episode dives into one such moment: when four friends, Pat Morissey, Brendan Cusick, Peter Durso, and Scott Fo…

1
AI in biotech today, and how it will impact the industry tomorrow 39:40

5M ago39:40

39:40

AI is driving innovation across industries, including biotech, but where is its influence felt most and what opportunities for future impact are emerging? David del Bourgo is the co-founder and CEO of WhiteLab Genomics, an innovative biotech that is leveraging the power of AI to accelerate drug discovery and development from its Paris, Boston, and …

1
How Do You Feel with Parkinson’s? A Special Edition Webinar on Emotions (Webinar Audio) 1:17:31

5M ago1:17:31

1:17:31

Life with Parkinson’s comes with a vast range of emotions, wherever you are in your disease journey. Shock, grief, optimism, fear, denial, hope, humor and more can all be a part of the emotional landscape for people living with the disease and their loved ones. Tune into audio from this special edition Third Thursdays Webinar to listen to our panel…

1
Season 5 Episode 1 Misdiagnosis and mental health 42:28

5M ago42:28

42:28

Join me today as I speak with Kenneth and Paige Jobe. Kenneth shares his personal story of misdiagnosis, mental health challenges and a loving care partner that helped bring him through.By Teresa Jackson

1
Creating Synergy Across A Growing P2P Portfolio with Princess Margaret Cancer Foundation’s Steve Merker 28:54

5M ago28:54

28:54

In the early days of the P2P industry, most nonprofits concentrated on one tentpole P2P event—typically a walk or cycling program—which allowed them to align staffing, branding, and resources around a single, large-scale initiative, focusing on broad market appeal. However, as the industry has evolved, so too has the need to diversify offerings—bot…

1
How nanobodies will revolutionize immunotherapy 41:13

5M ago41:13

41:13

From llamas and camels to humans worldwide. Nanobodies are enjoying success in the clinic and experts are hailing these camelid-derived biologics as one of the next big things in immunotherapy. Kristian Reich is co-founder and CSO of MoonLake Immunotherapeutics. After a long and distinguished career as a clinician and researcher, Kristian helped to…

1
ALL ABOUT AGING AND AI in APRIL with LAWRENCE KOSICK – GET SET UP and DOR SKULER – INTUITION ROBOTICS & ELLIQ; Caregiver Stress & Cortisol Face; Parkinson’s Community Clusters & Michael J. Fox & NAC Research ... 1:33:45

5M ago1:33:45

1:33:45

We are kicking off April with what is top of mind for everyone – how AI (artificial intelligence) is affecting and changing aging and caregiving. We have two experts in this area: Lawrence Kosick, Co-Founder of Get Set Up and Dor Skuler, Founder and CEO of Intuition Robotics, makers of ElliQ. They talk about how they are using AI to help both older…

1
Meeting the global demand for cell therapies: scaling with smart manufacturing 39:38

5M ago39:38

39:38

Cell therapies are at the cutting edge of personalized medicine but as demand for these therapies grows, how will the industry scale manufacturing to meet patient needs? Fabian Gerlinghaus is co-founder and CEO of Cellares. He and his team have developed the Cell Shuttle, an advanced cell manufacturing technology that is already demonstrating the p…

1
Treating spinal cord injuries with stem cells 33:48

6M ago33:48

33:48

Spinal cord injuries impact millions of people worldwide and, unlike many chronic injuries, they usually arrive with no forewarning, impacting the young and old alike. Brian Culley is CEO of Lineage Cell Therapeutics and his company is now in the clinic with a stem cell therapy for spinal cord injuries. Learn why stem cells could be promising for t…

1
Sniff Test: Surprising New Learnings About Smell Loss and Parkinson’s (Webinar Audio) 56:15

6M ago56:15

56:15

Smell loss can be among the earliest signs of Parkinson’s disease (PD) and other neurodegenerative diseases, signaling changes in the brain years before other symptoms are noticeable. Because of the link between smell and brain health, researchers are very interested in understanding more about how people with smell loss go on to either develop a d…